These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19487906)

  • 1. The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection.
    Yerly S; Junier T; Gayet-Ageron A; Amari EB; von Wyl V; Günthard HF; Hirschel B; Zdobnov E; Kaiser L;
    AIDS; 2009 Jul; 23(11):1415-23. PubMed ID: 19487906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece.
    Skoura L; Metallidis S; Buckton AJ; Mbisa JL; Pilalas D; Papadimitriou E; Papoutsi A; Haidich AB; Chrysanthidis T; Tsachouridou O; Antoniadou ZA; Kollaras P; Nikolaidis P; Malisiovas N
    J Antimicrob Chemother; 2011 Dec; 66(12):2831-7. PubMed ID: 21933785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations.
    Vega Y; Delgado E; Fernández-García A; Cuevas MT; Thomson MM; Montero V; Sánchez M; Sánchez AM; Pérez-Álvarez L;
    PLoS One; 2015; 10(5):e0125699. PubMed ID: 26010948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological network analysis in HIV-1 B infected patients diagnosed in Italy between 2000 and 2008.
    Callegaro A; Svicher V; Alteri C; Lo Presti A; Valenti D; Goglio A; Salemi M; Cella E; Perno CF; Ciccozzi M; Maggiolo F
    Infect Genet Evol; 2011 Apr; 11(3):624-32. PubMed ID: 21292031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes.
    SPREAD programme
    AIDS; 2008 Mar; 22(5):625-35. PubMed ID: 18317004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal.
    Palma AC; Araújo F; Duque V; Borges F; Paixão MT; Camacho R;
    Infect Genet Evol; 2007 Jun; 7(3):391-8. PubMed ID: 17360244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infections.
    Ambrosioni J; Junier T; Delhumeau C; Calmy A; Hirschel B; Zdobnov E; Kaiser L; Yerly S;
    AIDS; 2012 Oct; 26(16):2079-86. PubMed ID: 23052354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission of drug-resistant HIV-1 is stabilizing in Europe.
    Vercauteren J; Wensing AM; van de Vijver DA; Albert J; Balotta C; Hamouda O; Kücherer C; Struck D; Schmit JC; Asjö B; Bruckova M; Camacho RJ; Clotet B; Coughlan S; Grossman Z; Horban A; Korn K; Kostrikis L; Nielsen C; Paraskevis D; Poljak M; Puchhammer-Stöckl E; Riva C; Ruiz L; Salminen M; Schuurman R; Sonnerborg A; Stanekova D; Stanojevic M; Vandamme AM; Boucher CA
    J Infect Dis; 2009 Nov; 200(10):1503-8. PubMed ID: 19835478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance.
    Truong HM; Grant RM; McFarland W; Kellogg T; Kent C; Louie B; Wong E; Klausner JD
    AIDS; 2006 Nov; 20(17):2193-7. PubMed ID: 17086059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.
    Yerly S; von Wyl V; Ledergerber B; Böni J; Schüpbach J; Bürgisser P; Klimkait T; Rickenbach M; Kaiser L; Günthard HF; Perrin L;
    AIDS; 2007 Oct; 21(16):2223-9. PubMed ID: 18090050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
    Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
    Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.
    Bracciale L; Colafigli M; Zazzi M; Corsi P; Meraviglia P; Micheli V; Maserati R; Gianotti N; Penco G; Setti M; Di Giambenedetto S; Butini L; Vivarelli A; Trezzi M; De Luca A
    J Antimicrob Chemother; 2009 Sep; 64(3):607-15. PubMed ID: 19608581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations.
    Ahumada-Ruiz S; Flores-Figueroa D; Toala-González I; Thomson MM
    Infect Genet Evol; 2009 Sep; 9(5):933-40. PubMed ID: 19559103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrequent transmission of HIV-1 drug-resistant variants.
    Yerly S; Jost S; Telenti A; Flepp M; Kaiser L; Chave JP; Vernazza P; Battegay M; Furrer H; Chanzy B; Burgisser P; Rickenbach M; Gebhardt M; Bernard MC; Perneger T; Hirschel B; Perrin L;
    Antivir Ther; 2004 Jun; 9(3):375-84. PubMed ID: 15259900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV type-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity.
    Recordon-Pinson P; Anies G; Bruyand M; Neau D; Morlat P; Pellegrin JL; Groppi A; Thiébaut R; Dabis F; Fleury H; Masquelier B;
    Antivir Ther; 2009; 14(4):551-6. PubMed ID: 19578240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection.
    Booth CL; Geretti AM
    J Antimicrob Chemother; 2007 Jun; 59(6):1047-56. PubMed ID: 17449483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
    Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
    Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection.
    Booth CL; Garcia-Diaz AM; Youle MS; Johnson MA; Phillips A; Geretti AM
    J Antimicrob Chemother; 2007 Mar; 59(3):517-24. PubMed ID: 17213262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 transmission cluster with M41L 'singleton' mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual men.
    Lindström A; Ohlis A; Huigen M; Nijhuis M; Berglund T; Bratt G; Sandström E; Albert J
    Antivir Ther; 2006; 11(8):1031-9. PubMed ID: 17302373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of primary genotypic resistance in a UK centre: Comparison of primary HIV-1 and newly diagnosed treatment-naive individuals.
    Fox J; Hill S; Kaye S; Dustan S; McClure M; Fidler S; Mackie NE
    AIDS; 2007 Jan; 21(2):237-9. PubMed ID: 17197816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.